TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CSBR

Champions Oncology Inc

Healthcare · Biotechnology

5.10$ +0.0% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Champions Oncology Inc (CSBR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 43.8% of the shares are freely tradable; institutional investors hold 47.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 47.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 26.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 43.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 1.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 14Mio.

Largest Shareholders

Institutions

Institutions CSBR
Name Stake (%) Shares Change (%) Date
Battery Management Corp 17.40 2,421,673 +0.0 06/30/2026
NEA Management Company, LLC 12.31 1,713,720 +0.0 03/31/2026
Tocqueville Asset Management L.P. 2.30 319,674 +0.0 03/31/2026
Vanguard Capital Management, LLC 2.15 299,520 +0.0 03/31/2026
Morgan Stanley - Brokerage Accounts 1.74 242,300 +5.5 03/31/2026
Renaissance Technologies Corp 1.05 145,539 -6.0 03/31/2026
BlackRock Inc 0.89 123,900 +0.9 03/31/2026
Mink Brook Asset Management LLC 0.80 111,338 +0.0 06/30/2026
Geode Capital Management, LLC 0.55 77,177 +1.8 03/31/2026

Funds

Funds CSBR
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.65 229,971 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?